BioSupply Trends Quarterly logo
Search
Close this search box.
Subscribe
Spring 2024 - Safety
  Download Issue
Share

Up Front

Publisher's Corner
First Do No Harm: Increasing Patient Safety
By Patrick M. Schmidt

Features

Image of woman with mental health provider

Caring for Mental Health in a World of Uncertainty

image of clinical trial components

Solving Clinical Trial Delays by Accelerating Patient Recruitment

Mitigating AI Risks Feature Image

Mitigating AI Risks for Consumer Health Misinformation

Improving Patient Safety Feature Art

Improving Patient Safety in the Primary Care Setting

Image of woman laying awake

Myths & Facts: Sleep Disorders

image of mosquito

Update on Malaria

BioTrends Watch

Washington Report
New Rule Expands Access to Health Information and Improves Prior Authorization Process
CMS Finalizes Rule to Advance Health Equity
$13M NIH Grant Funds Research to Rejuvenate Immune System in Older Adults
New Guidance Recommends All Federal Facilities Have Access to Naloxone
Reimbursement FAQs
Drug Reimbursement: Working with Payers
Healthcare Management
Is Hybrid Care the Future?
Industry News
Discovery Could Predict Immunotherapy Response in Melanoma
Researchers Identify an Immune Cell That Can Attack Cancer
Study Uses Flu Virus to Speed Up COVID-19 Antibodies
Study Will Test Vaccine That Kills Cancer Cells Without Side Effects
Study Shows New Blood Test May Predict Alzheimer’s Risk
First Cancer Patients Receive mRNA Therapy in Clinical Trial
FDA Approves New Safety Labeling for Opioid Medications
Study Shows Patients Vaccinated Against Ebola Are Half as Likely to Die Than Unvaccinated Patients
FDA Approves First Cell Therapy to Treat Melanoma
Third Humira Biosimilar Is Approved by FDA

BioFocus

Industry Insight
Cryoprecipitate, Fibrinogen Concentrates and New Pathogen Reduced Cryo Product Vie for Use in Massive Hemorrhage
By Keith Berman, MPH, MBA
Patient Profile
Anxiety: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
Anxiety: A Physician’s Perspective
By Trudie Mitschang
MyFluVaccine.com

BioSources

BioResearch
Albumin Administration Superior to Ringer’s Lactate for Maintaining Normovolemia During Major Surgical Hemorrhage
Emicizumab Prophylaxis Efficacious and Well-Tolerated in Infants with Severe Hemophilia A Without Inhibitors
BioSupply Trends Quarterly logo
FFF Enterprises logo
Facebook-f Instagram Linkedin-in Youtube
FFF Enterprises.com | Privacy Statement | Terms of Use |

FFF Enterprises.com
Privacy Statement
Terms of Use

©2024 FFF Enterprises, Inc. All Rights Reserved. Property of FFF Enterprises, Inc.

The information provided on this website is not medical advice, nor is it intended to be a substitute for medical advice, diagnosis, and treatment. Always seek the advice of a physician or other qualified health provider with questions concerning a medical condition. Never disregard professional medical advice, or delay seeking it based on information provided on this website.